subscribeSubscribe
price-trendAsk Us
The Biopharmaceutical Cartel And High Drug Prices

The Biopharmaceutical Cartel And High Drug Prices
John LaMattina FORBES
10 Apr 2019
Share Share
Japan`s PMDA reviews hep B risk link to hep C therapies

Japan`s PMDA reviews hep B risk link to hep C therapies
EJ Lane FIERCE ASIA
04 May 2016
Share Share
FDA Calls for Head-to-Head Trials in Revised Draft Guidance on Hepatitis C

FDA Calls for Head-to-Head Trials in Revised Draft Guidance on Hepatitis C
Michael Mezher RAPS
03 May 2016
Share Share
Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst

Gilead meds face little threat from hep C rivals Merck, BMS and AbbVie: analyst
Tracy Staton FIERCE PHARMA MARKETING
31 Mar 2016
Share Share
AbbVie Receives CHMP Positive Opinion for VIEKIRAX®+ EXVIERA®Without Ribavirin

AbbVie Receives CHMP Positive Opinion for VIEKIRAX®+ EXVIERA®Without Ribavirin
PR NEWSWIRE
26 Feb 2016
Share Share
FDA expands use of Gilead`s liver drug to rare subset of patients

FDA expands use of Gilead`s liver drug to rare subset of patients
Amrutha Penumudi REUTERS
17 Feb 2016
Share Share
Risk of Serious Liver Injury associated with Hepatitis C Treatments

Risk of Serious Liver Injury associated with Hepatitis C Treatments
HEALTH CANADA
10 Nov 2015
Share Share